Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00127907Phase 4Completed
Phase 4, randomised trial of vasopressin in cardiac arrest (SCA) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Survival at hospital admission. Started May 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00127907.